168 related articles for article (PubMed ID: 29146641)
1. Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway.
Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; de Lange T; Bagnardi V; Ursin G; Weiderpass E
BMJ Open; 2017 Nov; 7(11):e017639. PubMed ID: 29146641
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?
Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; Ursin G; Weiderpass E
Int J Cancer; 2017 Nov; 141(9):1763-1770. PubMed ID: 28685818
[TBL] [Abstract][Full Text] [Related]
3. The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer.
Lin KJ; Cheung WY; Lai JY; Giovannucci EL
Int J Cancer; 2012 Jan; 130(2):419-30. PubMed ID: 21365647
[TBL] [Abstract][Full Text] [Related]
4. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy and risk of colorectal cancer.
Johnson JR; Lacey JV; Lazovich D; Geller MA; Schairer C; Schatzkin A; Flood A
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):196-203. PubMed ID: 19124498
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy and ovarian cancer.
Mørch LS; Løkkegaard E; Andreasen AH; Krüger-Kjaer S; Lidegaard O
JAMA; 2009 Jul; 302(3):298-305. PubMed ID: 19602689
[TBL] [Abstract][Full Text] [Related]
7. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone replacement therapy and risk of ovarian cancer.
Lacey JV; Mink PJ; Lubin JH; Sherman ME; Troisi R; Hartge P; Schatzkin A; Schairer C
JAMA; 2002 Jul; 288(3):334-41. PubMed ID: 12117398
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hormone therapy and the risk of breast cancer in Norway.
Román M; Sakshaug S; Graff-Iversen S; Vangen S; Weiderpass E; Ursin G; Hofvind S
Int J Cancer; 2016 Feb; 138(3):584-93. PubMed ID: 26289549
[TBL] [Abstract][Full Text] [Related]
10. The influence of hormone therapies on colon and rectal cancer.
Mørch LS; Lidegaard Ø; Keiding N; Løkkegaard E; Kjær SK
Eur J Epidemiol; 2016 May; 31(5):481-9. PubMed ID: 26758900
[TBL] [Abstract][Full Text] [Related]
11. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
12. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
[TBL] [Abstract][Full Text] [Related]
13. Stopping menopausal hormone therapy: if breast cancer really decreased, why did colorectal cancer not increase?
Nahum GG; Stanislaw H; Simon JA
Maturitas; 2012 Apr; 71(4):354-9. PubMed ID: 22300685
[TBL] [Abstract][Full Text] [Related]
14. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
[TBL] [Abstract][Full Text] [Related]
15. Pre-diagnostic body mass index and weight change in relation to colorectal cancer survival among incident cases from a population-based cohort study.
Laake I; Larsen IK; Selmer R; Thune I; Veierød MB
BMC Cancer; 2016 Jul; 16():402. PubMed ID: 27387027
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy and risk of ovarian cancer in postmenopausal women: a systematic review and meta-analysis.
Shi LF; Wu Y; Li CY
Menopause; 2016 Apr; 23(4):417-24. PubMed ID: 26506499
[TBL] [Abstract][Full Text] [Related]
17. Association of menopausal hormone therapy with gastric and colorectal cancer risks in Korean women: A nationwide population-based cohort study.
Baek C; Kim JE; Shin A; Choi JY
Maturitas; 2022 Dec; 166():35-40. PubMed ID: 36055009
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer death after adenoma removal in Scandinavia.
Emilsson L; Løberg M; Bretthauer M; Holme Ø; Fall K; Jodal HC; Adami HO; Kalager M
Scand J Gastroenterol; 2017 Dec; 52(12):1377-1384. PubMed ID: 28906163
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II.
Hildebrand JS; Jacobs EJ; Campbell PT; McCullough ML; Teras LR; Thun MJ; Gapstur SM
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2835-41. PubMed ID: 19843681
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.
Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K
PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
